SCHEDULE 13G

Company

GYRE THERAPEUTICS, INC.

Filed

February 26, 2007

Accession Number

0000904454-07-000111

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →